Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.

NCT02005900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

HIV-associated Hypertriglyceridemia
HIV-associated Hypercholesterolemia
HIV-associated Inflammatory State

Interventions

DRUG: Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborators

[object Object]
[object Object]